摘要
背景:线粒体乌头酸酶(Aco2)是含铁硫[4Fe-4S]的脱水酶家族的成员,通过三羧酸循环参与细胞代谢。 Aco2非常容易受到氧化损伤,因为暴露于活性物质和自由基会导致中心[4Fe-4S]簇中的铁释放,从而导致产生无活性形式的Aco2。 目的:越来越多的证据支持神经细胞中能量代谢受损与神经退行性疾病发生和发展之间的直接关联。 结果:已经表明生物能参数的改变是导致神经元功能障碍的神经退行性疾病的常见病理学特征。许多研究表明,功能失调的Aco2在其他生物能量参数中是促进神经变性的关键因素。 结论:增加我们关于能量代谢相关分子(包括受神经退行性疾病影响的Aco2)的知识可能有助于找到针对这些中枢神经系统相关疾病的有效治疗策略。因此,在这篇综述中,我们重点关注了神经变性中发生的事件和过程,导致大脑中Aco2的失活。
关键词: 线粒体乌头酸酶,神经退行性疾病,氧化应激,铁硫簇,阿尔茨海默氏病。
图形摘要
Current Drug Targets
Title:Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration
Volume: 19 Issue: 8
关键词: 线粒体乌头酸酶,神经退行性疾病,氧化应激,铁硫簇,阿尔茨海默氏病。
摘要: Background: Mitochondrial aconitase (Aco2), a member of the family of iron-sulfur [4Fe- 4S]-containing dehydratases, is involved in cellular metabolism through the tricarboxylic acid cycle. Aco2 is highly susceptible to oxidative damage in a way that exposure to the reactive species and free radicals leads to release of iron from the central [4Fe-4S] cluster resulting in the production of the inactive form of Aco2.
Objective: There is increasing evidence supporting a direct association between impaired energy metabolism and the incidence and progression of neurodegenerative disorders in neuronal cells.
Results: It has been shown that alteration in bioenergetic parameters is a common pathological feature of the neurodegenerative diseases leading to neuronal dysfunction. Numerous studies have demonstrated that dysfunctional Aco2, among the other bioenergetic parameters, is a key factor that could promote neurodegeneration.
Conclusion: Increasing our knowledge about energy metabolism-related molecules including Aco2 affected by neurodegenerative disorders might be useful to find an efficient therapeutic strategy for those central nervous system-related diseases. Accordingly, in this review, we have focused on the events and processes that occur in neurodegeneration, leading to the inactivation of Aco2 in the brain.
Export Options
About this article
Cite this article as:
Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration, Current Drug Targets 2018; 19 (8) . https://dx.doi.org/10.2174/1389450118666170816124203
DOI https://dx.doi.org/10.2174/1389450118666170816124203 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Current Alzheimer Research Soothing the Inflamed Brain: Effect of Non-Steroidal Anti-Inflammatory Drugs on Alzheimers Disease Pathology
CNS & Neurological Disorders - Drug Targets Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia
Current Protein & Peptide Science Small Molecules that Promote Neurogenesis in vitro
Recent Patents on CNS Drug Discovery (Discontinued) Cubosomes: Innovative Nanostructures for Drug Delivery
Current Drug Delivery MicroRNA Therapeutics in Neurological Disease
Current Pharmaceutical Design Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
CNS & Neurological Disorders - Drug Targets Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Chemical Biology: Past, Present and Future
Current Chemical Biology The Role of Peroxidation of Mitochondrial Membrane Phospholipids in Pancreatic β -Cell Failure
Current Diabetes Reviews Histone Deacetylation and Motor Neuron Degeneration
CNS & Neurological Disorders - Drug Targets Nicotinamide and its Pharmacological Properties for Clinical Therapy
Drug Design Reviews - Online (Discontinued) Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer’s disease
Current Pharmaceutical Design Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies
Current Psychopharmacology Exploring Structural and Physicochemical Profiles of Potential GSK-3β Inhibitors Using Structure- and Ligand-Based Modeling Studies
Combinatorial Chemistry & High Throughput Screening Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Current Pharmaceutical Design NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Use of Peripheral Blood Stem Cells in Tissue Engineering
Current Tissue Engineering (Discontinued) Adult Stem Cell Treatment for Central Nervous System Injury
Current Tissue Engineering (Discontinued)